Cargando…
SUN-180 Successful Use of SGLT-2 Inhibitor Dapagliflozin in Three Patients with Renal Transplant and Diabetes: A Fruit for Thoughts
Background: Management of patients with diabetes and renal transplant could be challenging. Transplant patients use multiple immune suppressants; most of them are notorious in worsening or even trigger hyperglycemia. Many of these patients have to use multiple anti-hyperglyemic agents to attain adeq...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Endocrine Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553257/ http://dx.doi.org/10.1210/js.2019-SUN-180 |